BBNX financials
Beta Bionics (BBNX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
BBNX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $100.25M | $55.54M | -$71.68M | -$73.20M | -1.81 |
| 2024 | $65.12M | $35.89M | -$45.25M | -$54.76M | -1.28 |
| 2023 | $11.99M | $6.31M | -$35.85M | -$44.10M | -1.03 |
| 2022 | $179.00K | $179.00K | -$65.84M | -$64.75M | -1.51 |
- BBNX revenue was $100.25M in fiscal 2025, net income -$73.20M.
Updated 2026-11-07 11:56 UTC